Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan.
Hiramatsu N, Kasahara A, Nakanishi F, Toyama T, Tsujii M, Tsuji S, Kanto T, Takehara T, Kato M, Yoshihara H, Naito M, Katayama K, Hijioka T, Hagiwara H, Kubota S, Oshita M, Meren H, Masuzawa M, Haruna Y, Mita E, Suzuki K, Hayashi N. Hiramatsu N, et al. Among authors: kubota s. Hepatol Res. 2004 Jul;29(3):142-147. doi: 10.1016/j.hepres.2004.03.008. Hepatol Res. 2004. PMID: 15203077
Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C.
Oze T, Hiramatsu N, Kurashige N, Tsuda N, Yakushijin T, Kanto T, Takehara T, Kasahara A, Kato M, Yoshihara H, Katayama K, Kubota S, Hijioka T, Ishibashi K, Oshita M, Hagiwara H, Haruna Y, Mita E, Tamura S, Hayashi N. Oze T, et al. Among authors: kubota s. J Gastroenterol. 2006 Sep;41(9):862-72. doi: 10.1007/s00535-006-1858-2. J Gastroenterol. 2006. PMID: 17048050
Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
Hiramatsu N, Oze T, Tsuda N, Kurashige N, Koga K, Toyama T, Yasumaru M, Kanto T, Takehara T, Kasahara A, Kato M, Yoshihara H, Katayama K, Hijioka T, Hagiwara H, Kubota S, Oshita M, Haruna Y, Mita E, Suzuki K, Ishibashi K, Hayashi N. Hiramatsu N, et al. Among authors: kubota s. Hepatol Res. 2006 Jul;35(3):185-9. doi: 10.1016/j.hepres.2006.03.008. Epub 2006 May 4. Hepatol Res. 2006. PMID: 16678478
Treatment outcomes of primary salivary gland squamous cell carcinoma: A multi-institutional retrospective study in Japan.
Sato R, Kumai T, Kusaka T, Kano S, Ohkoshi A, Kubota S, Miyakura Y, Murayama K, Tagawa A, Godo S, Matsushita D, Tomizawa H, Toyoma S, Shirotori A, Takahara M. Sato R, et al. Among authors: kubota s. Auris Nasus Larynx. 2025 Jan 9;52(1):43-49. doi: 10.1016/j.anl.2024.12.008. Online ahead of print. Auris Nasus Larynx. 2025. PMID: 39793421
Rapidly progressive digital necrosis in polyarteritis nodosa.
Kubota S, Kobayashi Y, Hanai S, Nakagomi D. Kubota S, et al. Rheumatol Adv Pract. 2024 Dec 24;9(1):rkae153. doi: 10.1093/rap/rkae153. eCollection 2025. Rheumatol Adv Pract. 2024. PMID: 39781280 Free PMC article. No abstract available.
Predictors of recurrence and survival after salivary gland cancer surgery: A multicenter, retrospective study in northern Japan.
Ohkoshi A, Ishii R, Higashi K, Shishido T, Kano S, Kusaka T, Matsushita D, Murayama K, Miyakura Y, Kubota S, Sato R, Godo S, Tomizawa H, Toyoma S, Tagawa A, Shirotori A, Katori Y. Ohkoshi A, et al. Among authors: kubota s. Oral Oncol. 2025 Jan;160:107131. doi: 10.1016/j.oraloncology.2024.107131. Epub 2024 Dec 2. Oral Oncol. 2025. PMID: 39626322 Free article.
1,467 results